Skip to main content
Francesca Cottini, MD, Hematology, Columbus, OH, Ohio State University Wexner Medical Center

FrancescaCottiniMD

Hematology Columbus, OH

Hematologic Oncology

Assistant Professor, Division of Hematology

Dr. Cottini is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Cottini's full profile

Already have an account?

Summary

  • I am a hematologist who specializes in the treatment of patients with plasma cell disorders, such as multiple myeloma and amyloidosis. I completed my residency and hematology/medical oncology fellowship at The Ohio State University, where I became passionate about how the immune system affects myeloma growth, response to therapy and risk of infections.

    My laboratory research combines Multiple Myeloma (MM) biology and immunology to focus on the identification and validation of novel therapeutical targets, while my clinical research aims at defining strategies to improve the safety of autologous stem cell transplant or anti-MM therapies.

Education & Training

  • Ohio State University Hospital
    Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2017 - 2020
  • Ohio State University Hospital
    Ohio State University HospitalResidency, Internal Medicine, 2015 - 2017
  • Universita San Raffaele
    Universita San RaffaeleClass of 2009, MD, Cum laude

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2015 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • AACR Scholar-in-Training Award American Association for Cancer Research, 2014, 2017
  • Young Fellow Award International Myeloma Foundation, 2015
  • TRTH participant EHA-ASH Translational Research Training in Hematology, 2014

Publications & Presentations

PubMed

Abstracts/Posters

  • Characterization of Monoclonal Gammopathy of Undetermined Significance Progression to Multiple Myeloma through Meta-Analysis of GEO Data
    Francesca Cottini, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Aryl Hydrocarbon Receptor (AHR) Antagonism As a Transformative, Dual-Mechanism Novel Therapy for Multiple Myeloma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Professional Memberships

Other Languages

  • Italian, French

Hospital Affiliations